TWA
ARNA

TCI Wealth Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

TCI Wealth Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-712
Closed -$42K – 2624
2021
Q3 		$42K Buy
712
+599
+530% +$35.4K 0.01% 474
2021
Q2 		$8K Buy
113
+47
+71% +$3.06K ﹤0.01% 1163
2021
Q1 		$5K Buy
+66
New +$5.08K ﹤0.01% 1327
2017
Q1 		– Sell
-50
Closed -$1K – 1412
2016
Q4 		$1K Sell
50
-120
-71% -$1.86K ﹤0.01% 1283
2016
Q3 		$3K Sell
170
-50
-23% -$829 ﹤0.01% 908
2016
Q2 		$4K Hold
220
– – ﹤0.01% 806
2016
Q1 		$4K Hold
220
– – ﹤0.01% 797
2015
Q4 		$4K Sell
220
-50
-19% -$1.02K ﹤0.01% 767
2015
Q3 		$5K Sell
270
-50
-16% -$1.7K ﹤0.01% 647
2015
Q2 		$15K Sell
320
-50
-14% -$2.17K 0.01% 459
2015
Q1 		$16K Buy
+370
New +$17.2K 0.01% 387

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCI Wealth Advisors's ARNA Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 712 shares — an estimated $42K sold.

TCI Wealth Advisors first reported a position in ARNA in Q1 2015 and held it in 11 quarters. The position peaked at $42K in Q3 2021. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • TCI Wealth Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 712 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $42K.
  • TCI Wealth Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2015 and held it in 11 quarters.
  • TCI Wealth Advisors's Arena Pharmaceuticals Inc position peaked at $42K in Q3 2021.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.